Chewy (CHWY.US) 2026年第一季度业绩电话会
文章语言:
简
繁
EN
Share
Minutes
原文
会议摘要
Chewy Inc. reported robust Q1 FY2026 sales and customer growth, attributing success to its recurring revenue model and strategic initiatives. Despite a challenging macroeconomic environment, the company maintained confidence in its long-term growth prospects, projecting FY2026 net sales between $13.40 billion and $13.55 billion. Chewy adjusted its outlook, expecting active customer additions to trend towards the lower end of previous estimates. The company's acquisition of Modern Animal is anticipated to bolster revenue growth, albeit with a modest margin impact. Chewy remains committed to market share gains through pet health and AI initiatives, and plans to expand its veterinary care offerings, opening 10-12 clinics in FY2026. The company emphasized disciplined capital allocation, prioritizing free cash flow and shareholder returns, while navigating a complex consumer landscape.
会议速览
The CUNY First Q1 2026 earnings call discusses financial results, strategic initiatives, and forward-looking statements, emphasizing risks and uncertainties affecting future performance. Non-GAAP financial measures are reconciled, and a presentation is available on the investor relations website for further details.
Chewy delivered strong Q1 results with 7.7% net sales growth, 3.6% active customer increase, and record profitability, driven by auto-ship sales and strategic initiatives. The company highlighted the durability of its business model, particularly in a challenging consumer environment, and outlined plans for expanding its healthcare services and AI integration to enhance customer experience and operational efficiency.
Despite acknowledging a more challenging consumer environment affecting premiumization and product attach rates, Chewie updates its guidance to reflect a conservative outlook. However, the company's confidence in its business strength, share-gaining ability, and long-term growth algorithm remains intact. Chewie highlights improved go-to-market strategies, successful customer reactivation, and strategic initiatives in AI, fulfillment, and customer experience. The company thanks its team for disciplined execution and innovation, emphasizing a commitment to profitable growth, free cash flow, and shareholder value.
The company reported robust Q1 performance with 7.7% year-over-year sales growth, strong margin expansion, and significant free cash flow. Notable achievements include the successful integration of SmartPak, growth in Auto Ship sales, and strategic investments in Chewie Health and Vet Care. The acquisition of Modern Animal and a $600 million Term Loan B transaction were announced to support future growth initiatives while maintaining financial flexibility.
Chewy revises fiscal 2026 sales outlook to $13.4B-$13.55B, reflecting a softer consumer environment, while maintaining adjusted EBITDA margin guidance at 6.6%-6.8%. The company anticipates slower net pack growth, active customer additions towards the lower end of the previous range, and ongoing investments in strategic priorities. Despite the challenging backdrop, Chewy remains confident in long-term structural margin opportunities and free cash flow generation, expecting robust profitability gains and market share expansion.
During the Q&A session, the company emphasized its strategic initiatives and financial guidance, noting the impact of seasonal adjustments on margins and anticipating long-term growth through competitive advantages in pet care and e-commerce.
The dialogue discusses Chewy's investment strategies for maintaining and accelerating market share growth, consumer behavior trends observed across different cohorts, and the efficiency gains from AI investments. It highlights positive cohort trends, premiumization impacts, and strategic initiatives such as Chey health, vet care, and automation, alongside a cautious approach to product line expansions and shareholder capital return.
Discusses factors contributing to market share gains despite economic pressures, highlighting strong customer retention, increased branded searches, and resilience in key product categories, attributing challenges primarily to macroeconomic conditions.
The dialogue discusses maintaining a growth strategy above market rates through initiatives and execution quality, highlighting health-related categories. It also outlines post-acquisition plans for CDC and veterinary services, focusing on clinic expansion, integration, and synergy realization.
The dialogue discusses the impact of consumer behavior and macroeconomic trends on customer additions and revenue growth, with updates on active ads guidance and the effect of Amazon's entry into same-day grocery. The speaker reiterates the company's conservative approach, reflecting modest pressure on netback curves due to attach rate and premiumization headwinds, and maintains long-term revenue guidance of high single-digit to low double-digit growth.
The dialogue emphasizes maintaining a strong market position by focusing on innovation across various product categories and managing promotions strategically for higher ROI, while ensuring a consistent customer experience and business discipline.
The dialogue discusses the impact of discretionary spending trends on business growth, noting that while hardgoods remain strong, discretionary attach rates are below expectations. The conversation highlights the need for refined forecasting and the role of auto ship business in driving attach rates. The discussion also touches on promotional activities and their effectiveness in a rational industry environment.
The dialogue emphasizes focusing on expanding Total Addressable Market (TAM) and profitability sustainably, avoiding dilutive growth and low-quality customer acquisition through excessive marketing spend. It highlights the importance of Lifetime Value to Customer Acquisition Cost (LTV:CAC) ratio and ROI in investment decisions, contrasting with past ineffective promotional strategies.
The discussion covered updates on sponsored ads, highlighting their positive contribution to gross margin expansion and successful product launches like c-max. It also addressed the efficiency of customer acquisition costs for CDC versus primary digital channels, thanks to the strong brand halo effect. Lastly, the impact of Modern Animal on EBITDA margins was explained, noting a temporary headwind in Q2 that is expected to diminish over the year.
要点回答
Q:How did the company's performance in Q1 validate its position in the Pet category?
A:The company's Q1 performance validated its position in the Pet category by demonstrating the durability of its business model and structural advantages, even amidst a weakening consumer environment. The company continued to steadily gain share, with a strong value proposition including industry-leading convenience, competitive pricing, trusted service, a deep assortment, and a recurring auto-ship ecosystem that customers increasingly rely on.
Q:What is the significance of the adjusted EBITDA margin and profitability drivers mentioned?
A:The Q1 adjusted EBITDA margin of 7.5% represented a year-over-year expansion of approximately 130 basis points on the back of EBITDA flow-through greater than 25%. This level of profitability reflects strength across multiple business areas such as sponsored ads, category mix, supply chain efficiencies, marketing productivity, opex discipline, and operating leverage. The company remains on track to reach its 10% adjusted EBITDA margin target over time, driven by structural factors like the expansion of sponsored ads, product mix, the shift into higher-margin categories, and automation and scale.
Q:How is the company approaching the integration and potential growth with the acquisition of Modern Animals?
A:The company is excited about the recently announced acquisition of Modern Animals, which closed shortly after the quarter ended. This acquisition adds a highly complementary footprint with above-industry unit economics, strong clinical expertise, and an experience-led technology-enabled model. It is expected to accelerate the expansion of the company's vet clinics and unlock multiple avenues to clinic growth. After the integration, the company expects to operate approximately 60 clinics with an embedded revenue contribution of nearly $290 million at a steady state, which is anticipated to be a meaningful driver of long-term shareholder value.
Q:What are the company's expectations for AI implementation and its impact on the business?
A:The company continues to see AI as a meaningful opportunity for both customer experience and operational efficiency. Over the past few quarters, foundational infrastructure has been built to deploy AI across the enterprise. AI is being embedded across various business layers including customer service, pharmacy operations, fulfillment, and marketing workflows. AI-driven efficiencies are expected to contribute a low tens of millions of dollars benefit in fiscal 2026, with a more significant ramp-up expected into 2027 and beyond.
Q:How is the company performing in terms of customer acquisition and profitability?
A:The company is seeing strength in the customer acquisition funnel which supports sustained share gains across macro environments. It is also positioned to return to more typical netback compounding rates as consumer conditions normalize, with a significantly larger customer base. The strategic initiatives across AI fulfillment and customer experience continue to strengthen the ecosystem.
Q:What were the financial results and growth drivers in Q1?
A:Q1 net sales reached approximately $3.36 billion, with a 7.7% year-over-year growth, reflecting the continued strength across the recurring revenue base and active customer growth. The company ended the quarter with approximately 21.5 million active customers, a year-over-year increase of 3.6%. Auto ship customer sales reached approximately $2.83 billion, growing over 10% year over year. Q1 gross margin expanded by 50 basis points to 30.1%, with non-GAAP operating expenses at $593 million, or 17.7% of net sales. Adjusted net income was approximately $180 million, with adjusted diluted earnings per share at 43 cents.
Q:What strategic priorities did the company focus on in the quarter and what was the impact on capital deployment?
A:During the quarter, the company focused on several strategic priorities, including the acquisition of smartpak and approximately $200 million of share repurchases under its existing program. This reflects the company's confidence in the long-term opportunity and its disciplined approach to capital allocation. The company ended the quarter with approximately $520 million of cash, cash equivalents, and marketable securities, and over $1 billion of total available liquidity.
Q:What is the updated full-year fiscal 2026 net sales outlook and what factors influenced this change?
A:The updated full-year fiscal 2026 net sales outlook has been revised to reflect the softer consumer environment and more conservative internal assumptions for the balance of the year. The company now expects net sales of between approximately $13.40 and $13.55 billion, representing approximately 6.3% to 7.5% year-over-year growth. The range includes an expected net sales contribution of approximately $80 million from Smart P and $70 million from modern animal for fiscal year 2026.
Q:What is the updated profitability guidance for the year and how does the modern animal acquisition impact it?
A:The full year fiscal 2026 adjusted EBITDA margin guidance range is maintained at 6.6% to 6.8%, representing approximately 100 basis points of year-over-year expansion at the midpoint. However, the modern animal acquisition is expected to result in a modest margin rate drag, indicating the increasing durability of Chewy's earnings algorithm.
Q:What strategic priorities are being reflected in the updated profitability outlook?
A:The updated profitability outlook continues to reflect ongoing investment across several strategic priorities such as QWI health, QWI vet care, automation initiatives, AI-enabled productivity efforts, and continued customer and acquisition investments.
Q:How is the revenue growth expectation for the second quarter affected by the challenging consumer backdrop?
A:Revenue growth expectations for the second quarter have been moderated to reflect the current operating environment. However, the company continues to expect gross margin expansion on a full year basis and profitability improvements despite more muted EBIT margin expansion in the second quarter relative to the first quarter.
Q:How does the updated guidance for fiscal year 2026 take into account the fuel cost headwinds?
A:The updated guidance for fiscal year 2026 contemplates similar levels of fuel cost headwinds for the balance of the year. The company expects strong year-over-year profitability expansion across the back half of fiscal 2026, as reflected in the full year guide, despite more muted second quarter adjusted EBITDA margin expansion due to one-time map item impacts.
Q:What is the expected pattern of SNA expansion in Q2 and how will it affect the growth margin?
A:The expected pattern of SNA expansion in Q2 is a phasing that will result in a more stable quarter-over-quarter growth margin. Q2's results are structured to smooth out the previously higher and outsized increase seen in Q1, leading to a more normal seasonal pattern with growth continuing to expand year-on-year in the back half of the year.
Q:How is SNA expected to leverage costs and what impact will it have on gross margin?
A:SNA is expected to leverage costs with fulfillment costs and corporate payroll costs. The impact on gross margin is positive, with continued expansion attributed to sponsored AS premiumization and a rational promotional environment.
Q:What types of data are not collected by the company on a periodic basis and what is the observed trend regarding customer behavior?
A:The company does not collect data on consumer demographics on a periodic basis but looks at trends such as cumulative reorder rates for customers, which show positive trends for both new and reactivated customers. The observed trend is that these customer segments are showing positive cohort trends.
Q:How does the company plan its long-term platform and product initiatives and what is the investment strategy?
A:The company plans long-term platform and product initiatives twice a year and breaks these plans down into annual increments. Investments are expected to drive market share growth, improve the customer share, and enhance the gross margin. Specific investments include building up infrastructural capabilities, investing back in AI, and focusing on initiatives like Chewy Health, which includes Vet Care and Clinic initiatives.
Q:What product initiatives are driving better sell-through curves and what is the impact of the mentioned projects on the margin investment?
A:Product initiatives that drive better sell-through curves include those that promote repeat or in-person behavior and improve the customer experience. Some projects that were initially considered bullish, like auto-ship attachments, are being closely evaluated for potential changes in consumer behavior. Investments in areas such as automation and AI are continuing, which drivesSGNA curve leverages while maintaining strong corporate payroll discipline. Investments are being evaluated to ensure that profit is maximized and converted into free cash flow.
Q:What factors indicate the market share gains and how confident is the company about its position in the face of a weaker宏观 environment?
A:Factors indicating market share gains include solid customer retention driven by the company's efforts, stronger branded searches and direct traffic migrating to the company's platform, and an industry-level trend showing weakening in pet food and supplies impressions. The company's products maintained mid-single-digit percentage growth in sales across all categories, and it continues to see strong consumer spending behavior in certain categories. Lower churn, healthier reactivation rates, and modestly worse-than-expected new customer acquisition also contribute to the company's confidence that the pressure it's experiencing is primarily macro-related and not due to increased competition or share loss.
Q:What is the expected growth pattern for the company in the mid to longer term, and how does it relate to the industry growth rate and the company's initiatives?
A:The company expects to continue growing and to grow more relative to the market. The value proposition of how they are going to market is strengthening across broader initiatives where they are expanding the Total Addressable Market (TAM), improving precision and quality of execution, and gaining meaningful share in health-related categories. None of the expectations or aspirations have changed regarding the ability to accrue market share and drive outsized growth relative to the market.
Q:How many clinics does the company plan to open in fiscal 2026?
A:The company plans to open 10 to 12 clinics in fiscal 2026 as per their stated record.
Q:What is the projected net space exit for the company by the end of fiscal 2026?
A:The projected net space exit for the company by the end of fiscal 2026 is expected to be around 120,000 to 140,000 customers.
Q:What recent changes in consumer behavior have impacted the company's guidance and forward commentary?
A:Recent changes in consumer behavior that have impacted the company's guidance and forward commentary include a decrease in gross adds and an acceleration in churn rates. The company has observed a reset in the market with a weaker macro environment and a competitive impact from Amazon's entry into same-day grocery. This has led to an update in guidance, resulting in an expectation for modest pressure on net adds due to attach rates and premiumization headwinds.
Q:How does the company view its competitive position in the market?
A:The company does not see any change in the competitive environment and continues to focus on its customer proposition. They are confident in their market positioning, which is being driven by innovation in classic products that serve the food and supply segments, as well as in new categories such as health, equine, and animals. The company feels positive about its position regarding pricing and promotional intensity, which is consistent with a rational retail environment. The focus remains on delivering a strong customer experience while maintaining the business with appropriate discipline.
Q:What is the reason for the lower-than-expected discretionary attach rate?
A:The lower-than-expected discretionary attach rate is not due to a decline in hardgood demand but rather the base of discretionary attachments is running below expectations. This means that while customers are still purchasing discretionary categories, they are being more deliberate in their spending decisions.
Q:What initiatives are driving the attachment rate for discretionary items?
A:The attachment rate for discretionary items is being driven by the company's product expansion, where the hardgoods assortment remains healthy and supports growth. Additionally, the auto-ship business has continued to grow strongly, which is a premium driver of attachment. Some non-CS driven behaviors have also impacted the attachment rate, such as customers adding line items to auto-ship.
Q:What is the company's view on promotions and investment in the business?
A:The company views investment in the business as important and does not focus on promotions as a lever for growth. They are interested in expanding TAM and profitability on a sustainable basis rather than chasing dilutive growth. They are also careful about not overinvesting in marketing to avoid picking up lower-quality customers. The focus is on the ROI of investments and keeping a disciplined approach with LTV to CAP.
Q:How is the sponsored ads initiative contributing to gross margin expansion?
A:The sponsored ads initiative is continuing to be a primary growth driver of margin contribution. The program is growing and will continue to mix into off-site ads. The company is pleased with the progress and efforts to accelerate product launches, such as 'c-max', which helps advertisers collaborate faster and solve cold start challenges. The initiative is also helping offset some of the fuel pressures. Overall, it remains a product with high customer reception and strong scores from advertisers, with a focus on optimizing supply and ramping up off-site ads.
Q:What is the customer acquisition cost for clinic acquired customers versus primary digital channels?
A:The customer acquisition cost for clinic acquired customers has been a pleasant surprise for the company. The halo effect of the Chey brand has attracted high-quality customers with little local activation, making the overall acquisition costs efficient. This behavior has been consistent with every box drop in the last 18 boxes, and the company is pleased with the customer acquisition costs after operating the infrastructure for 2.5 years, helped by the brand awareness.
Q:How significant is the EBITDA margin headwind from Modern Pet in Q2 guidance?
A:The EBITDA margin headwind from Modern Pet is expected to be generally dollar-neutral in 2026. There is a net sales impact of $70 million for the year with a modest margin rate drag for the year. This drag is anticipated to be higher in Q2 and diminish through the year. The overall view for Modern Pet's impact is that it will be generally dollar-neutral in 2026.

Chewy, Inc.
Follow





